Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Improved Cornea Surgery Technique Enhances Transplant Success

By HospiMedica staff writers
Posted on 20 Nov 2007
A modified ophthalmologic surgical technique significantly improves results in patients being treated for endothelial disease of the cornea, according to a new study.

Researchers at the Villa Serena Hospital (Forli, Italy) developed a modified descemet-stripping automated endothelial keratoplasy (DSAEK) technique that resulted in rates of donor endothelial cells survival equivalent to the standard surgical approach, penetrating keratoplasy (PK, otherwise known as complete cornea transplantation). More...
The modified technique was developed in response to a significant drawback of the standard DSAEK procedure, which results in limited survival of the transplanted endothelium, with a reduction of up to 50 % of preoperative density as early as six months after surgery. The study was presented at the annual meeting of the American Academy of Ophthalmology, held during November 2007 in New Orleans (LA, USA).

"Our approach reduced the rate of endothelial cell loss in the transplanted tissue to an average of 23% at one year post-surgery, which is similar to values recorded after PK,” said lead author professor of ophthalmology Massimo Busin, M.D. "Our 'pull through' technique simplifies the DSAEK procedure and, more importantly, resolves the main obstacle that has delayed corneal surgeons' transition to DSAEK.”

In DSAEK, the diseased Descemet's membrane is removed, attached to a thin layer of deep stroma, and the normal structure of the recipient cornea is not disrupted, leaving the eye much stronger and less prone to injury than full-thickness transplants. DSAEK uses only a small incision that is either self-sealing or may be closed with a few sutures. Because the procedure is less invasive, vision is typically restored in one to three months rather than one to two years in PK, and the risk of complications during and after surgery is minimized.


Related Links:
Villa Serena Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.